Sino Biopharmaceutical Ltd
OTC:SBHMY
Relative Value
The Relative Value of one
SBHMY
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 15.89 USD,
Sino Biopharmaceutical Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
SBHMY Competitors Multiples
Sino Biopharmaceutical Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HK |
|
Sino Biopharmaceutical Ltd
OTC:SBHMY
|
121.7B USD | 3.5 | 28 | 15.9 | 15.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
973.8B USD | 14.9 | 47 | 31.7 | 33.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
575.5B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
281.3B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
224.5B GBP | 5.4 | 33.5 | 16 | 23.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
235.1B CHF | 5.4 | 21.6 | 13.3 | 17.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
292.2B USD | 4.5 | 16 | 10 | 11.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.3 | 9.7 | 11.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.5B USD | 2.5 | 20.2 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.8B USD | 2.6 | 17.6 | 6.9 | 8.8 |